Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Emyria Ltd ( (AU:EMD) ) just unveiled an announcement.
Emyria Limited has announced a significant expansion of its services with a new funding agreement from Medibank Private Ltd. This agreement will allow eligible patients to access Emyria’s mental health programs for TRD and PTSD at the new Empax Clinic in Brisbane, marking the company’s first insurer-backed services on Australia’s East Coast. This expansion is part of Emyria’s national growth strategy to address the mental health burden in Australia by providing affordable and coordinated treatment options. The collaboration with Medibank is expected to reduce financial barriers for patients and demonstrates the scalability of Emyria’s care model, positioning the company as a leader in evidence-based mental health care.
More about Emyria Ltd
Emyria Limited is a leader in delivering evidence-based mental health treatments, focusing on programs for Treatment-Resistant Depression (TRD) and Post-Traumatic Stress Disorder (PTSD). The company is expanding its insurer-backed services beyond Western Australia, establishing a presence on Australia’s East Coast to strengthen its national leadership in mental health care.
Average Trading Volume: 4,603,324
Technical Sentiment Signal: Buy
Current Market Cap: A$45.89M
For detailed information about EMD stock, go to TipRanks’ Stock Analysis page.